NCT02755441Active, not recruiting
Pulmonary Fibrosis Biomarker Cohort - a Prospective Cohort of Incident Patients With IPF
Pulmonary Fibrosis Biomarker Cohort (PFBIO)
Source: ClinicalTrials.gov · Last updated 22 Dec 2023
Brief summary (registry, in English)
Incident patients with idiopathic pulmonary fibrosis (IPF) in Denmark will be offered inclusion and followed up for up to 5 years with measurements of blood biomarkers and measurements of disease progression.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 450 (estimated)
- First submitted
- 19 Apr 2016
- Start date
- 1 Apr 2016
- Primary completion date
- 31 Dec 2023
- Lead sponsor
- Nils Hoyer
- Diseases
- Idiopathic pulmonary fibrosis
- NCT number
- NCT02755441
What you commit to
- Study type: Observational
- Planned participants: 450
- From 1 Apr 2016 to the primary completion date, 31 Dec 2023
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Age lower than 18 years
Other
- Unable to provide informed consent to participation
Who the study is looking for
- Diagnosis of idiopathic pulmonary fibrosis according to the 2011 guidelines by the American Thoracic Cosicety (ATS) and European Respiratory Society (ERS)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Aarhus University Hospital Coordinator of this site? Confirm its status | Aarhus | Denmark | Unknown status |
| Gentofte Hospital Coordinator of this site? Confirm its status | Hellerup | Denmark | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.